Viscoryl A represents a professionally formulated expectorant syrup designed to address a comprehensive range of respiratory conditions. Each 5 ml contains precisely measured Ambro...

Viscoryl A represents a professionally formulated expectorant syrup designed to address a comprehensive range of respiratory conditions. Each 5 ml contains precisely measured Ambroxol HCl 15 mg, Terbutaline Sulphate 1.25 mg, Guaiphenesin 50 mg, and Menthol, working in perfect synergy to deliver effective relief from cough, bronchospasm, and mucus congestion. This powerful combination ensures rapid action in loosening phlegm, expanding airways, and soothing throat irritation, establishing it as a preferred choice among healthcare providers worldwide. Manufactured under stringent quality controls in certified facilities, the syrup guarantees consistency, safety, and reliability for end-users. The pleasant flavor profile significantly enhances patient compliance, particularly in pediatric and geriatric populations who often struggle with medication adherence. Businesses can confidently rely on Viscoryl A for its proven efficacy and strict adherence to international pharmaceutical standards.

This advanced respiratory solution finds extensive application across multiple healthcare sectors, including hospitals, clinical practices, retail pharmacy chains, and community health initiatives. It serves as a cornerstone product in treating respiratory issues prevalent in regions affected by high pollution levels, seasonal climate changes, and industrial activity. Pharmaceutical distributors and wholesalers consistently stock Viscoryl A due to its sustained high demand in markets specializing in asthma, bronchitis, and COPD management. The product also plays a crucial role in preventive healthcare and wellness programs aimed at reducing respiratory morbidity rates. Industries with significant occupational health considerations, particularly manufacturing, construction, and mining sectors, frequently include this syrup in their first-aid supplies and employee wellness kits to address work-related respiratory concerns.

Viscoryl A delivers substantial business value through its unwavering reliability, consistent performance, and market readiness. The unique formulation distinguishes itself by perfectly balancing therapeutic efficacy with patient safety, significantly reducing the risk of adverse effects while building patient trust and confidence. For serious buyers in the pharmaceutical supply chain, this translates to predictable repeat orders, enhanced customer satisfaction, and strengthened brand reputation in competitive markets. The product's compliance with international quality standards ensures smooth import processes and distribution operations, minimizing regulatory hurdles and logistical challenges. Investing in Viscoryl A means partnering with a product that promises consistent therapeutic performance, meets rigorous quality benchmarks, and delivers strong returns in the dynamic pharmaceutical marketplace.

Key Features:
- Contains Ambroxol HCl 15 mg per 5 ml for powerful mucus clearance and expectorant action
- Includes Terbutaline Sulphate 1.25 mg to effectively relieve bronchospasm and improve breathing
- Formulated with Guaiphenesin 50 mg to enhance expectorant action and mucus thinning
- Added Menthol for soothing throat irritation and providing refreshing palatability
- Manufactured under strict quality controls ensuring batch-to-batch consistency

Benefits:
- Provides comprehensive respiratory relief through multi-action formulation
- Ensures rapid symptom relief with fast-acting therapeutic components
- Enhances patient compliance through pleasant taste and easy administration
- Offers reliable performance backed by stringent manufacturing standards
- Supports respiratory health across diverse patient demographics and conditions